Undecimal Bio launches with $18M Read in browser

Thank you for reading, Test Researcher! basic Subscription UPGRADE

Mon T W Th F 12 October, 2026

sponsored by Join healthcare's #1 must-attend innovation event HLTH USA convenes top healthcare professionals and innovators to shape the future of health through unparalleled networking, insightful discussions, and innovative solutions. Register Today

presented by Greater em­pa­thy, greater ef­fi­cien­cy: How pa­tient-first clin­i­cal de­vel­op­ment ben­e­fits all of us

news AstraZeneca blames trial design for Phase 3 failure of bone disease drug Exclusive: Undecimal Bio launches with $18M to take siRNA beyond the liver Parkinson's cell therapy biotech Aspen Neuroscience and I&I startup Bambusa file for IPOs

Nov 12 12:30 pm ET From data to diagnostic: How AI is powering biomarker discovery sponsored by Guardant Health Nov 03 11:30 am ET Trust, not autonomy: Deploying agentic AI in GxP environments sponsored by Katalyze AI Nov 04 11:00 am ET Cutting through the noise: How biopharma is actually using AI to scale oncology research sponsored by Flatiron Health Oct 28 10:30 am ET The evolution of MRD: From molecular detection to clinical decisions sponsored by ABBOTT Oct 13 11:00 am ET Commercial excellence and AI - a ripple, wave or a tsunami sponsored by ZS Oct 15 1:00 pm ET Insights into Polycystic Kidney Disease: The Potential of Clinicogenomic Data sponsored by Natera Oct 20 11:00 am ET Intelligent oversight and orchestration: How mission control is redefining R&D decision-making sponsored by ZS Oct 21 11:00 am ET From prediction to decision: Digital twins and predictive modeling in clinical development sponsored by Flatiron Oct 22 11:00 am ET A new model for clinical research – Expanding community trial access sponsored by Parexel

Biopharma's balance of power is shifting, and in January, Endpoints journalists will press the people at the center of it on who's rising, who's falling and where the industry may land by the end of the decade. Join us at #JPM27 for exclusive conversations and interviews you won't get anywhere else. Save $200 on your all-access pass with Early Bird, or join us virtually for free.

ENDPOINTS PHARMA Curium prices generic radioligand at 5% discount to Novartis' Lutathera Acting general counsel at HHS has left the department Peer Review Viking commercial chief is out in a hurry; Gilead looks to BeOne exec for China expansion